Accurate enumeration of behavioral health workforce supply and characteristics is important for workforce planning. Although numerous data sources exist for the behavioral health workforce, all have substantial data limitations and comparability across data sources is low. A behavioral health workforce Minimum Data Set (MDS) was developed in 2016 to improve data quality. This qualitative report…
A large percentage of patients experiencing behavioral health issues seek help in primary care settings. Most are discharged without receiving behavioral health treatments. Furthermore, roughly half of all care for common psychiatric disorders is provided in primary care settings, and patients are often more open to discussing mental health concerns with their primary care physicians….
Currently, around 47.6 million Americans are living with a mental illness and 20.3 million adults are living with a substance use disorder (SUD). In 2016, only 43% (20.6 million) of adults living with any mental illness received mental health (MH) care, and only 3.7 million adults (18.2%) living with an SUD received any treatment. Peer…
The psychiatric workforce shortage remains a serious issue in the field of behavioral health. In 2018, the Health Resources and Services Administration (HRSA) designated 5,124 mental health professional shortage areas in the United States. Demand for the psychiatry workforce is projected to exceed the supply by 16,450 workers by 2030. Studies continue to show that…
Mental Health Counselors (MHCs) are a large and rapidly growing segment of the mental health workforce. However, little is known about this workforce other than its education and training requirements. This report describes a study that utilized an online survey to examine the characteristics of the current MHC workforce for the purposes of developing a…
Medication-assisted treatment (MAT) has been shown to be effective for treating opioid use disorders (OUDs), but implementation is lagging, particularly in rural areas. Telehealth may be an effective solution for helping to make MAT more accessible for patients suffering from OUDs in geographically remote areas. This report described a study that utilized geospatial analysis and…
Novel approaches to providing access to behavioral health care, like collaborative care and integrated behavioral health primary and social care models, have shown short and long-term positive patient and family outcomes in frontier, rural, and urban communities. These approaches are complex and rely upon coordination, systems-based management, efficient communications, team and community relationships, and virtual…
Unmet need for behavioral health care remains high. Behavioral health provider shortages and associated maldistribution of practitioners across the country may contribute to suboptimal behavioral healthcare availability, with an estimated 59.8% of the 5,035 mental health provider shortage areas in the US located in rural and partially rural areas. In addition, lack of access to…
There is demonstrated evidence that medications used for treating opioid use disorder (MOUD)—such as buprenorphine, methadone, and extended-release naltrexone—are effective at treating opioid use disorder (OUD) and reducing associated harms. However, these medications are heavily underutilized, largely due to the under-supply of providers trained and willing to prescribe the medications. This article discusses physicians’ comparative…
Buprenorphine is shown to be an effective medication for the treatment of opioid use disorder. It promotes long-term recovery and decreases the risk of mortality. Although Medicaid programs largely cover buprenorphine products, many continue to apply prior authorization (PA) requirements. This report studies how state Medicaid programs apply PA requirements to buprenorphine products.ArrayReport Arrayhttps://www.healthworkforceta.org/wp-content/uploads/2023/07/BHWRC_Coverage-of-Buprenorphine-Medications.pdfFebruary 2,…
